| https://dblp.org/rdf/schema#authoredBy
|
https://dblp.org/pid/98/5886-2 +
, https://dblp.org/pid/213/6751 +
, https://dblp.org/pid/255/5488 +
, https://dblp.org/pid/24/2594 +
, https://dblp.org/pid/163/5615 +
, https://dblp.org/pid/47/5740 +
, https://dblp.org/pid/175/2058 +
, https://dblp.org/pid/266/4801 +
, https://dblp.org/pid/90/5064-20 +
, https://dblp.org/pid/28/10841 +
, https://dblp.org/pid/189/1605 +
, https://dblp.org/pid/67/237 +
, https://dblp.org/pid/71/2791-4 +
|
| https://dblp.org/rdf/schema#bibtexType
|
http://purl.org/net/nknouf/ns/bibtex#Article +
|
| https://dblp.org/rdf/schema#documentPage
|
https://doi.org/10.1093/BIB/BBY130 +
|
| https://dblp.org/rdf/schema#doi
|
https://doi.org/10.1093/BIB/BBY130 +
, http://dx.doi.org/10.1093/BIB/BBY130 +
|
| https://dblp.org/rdf/schema#listedOnTocPage
|
https://dblp.org/db/journals/bib/bib21 +
|
| https://dblp.org/rdf/schema#numberOfCreators
|
13
|
| https://dblp.org/rdf/schema#pagination
|
649-662
|
| https://dblp.org/rdf/schema#primaryDocumentPage
|
https://doi.org/10.1093/BIB/BBY130 +
|
| https://dblp.org/rdf/schema#publishedIn
|
Briefings Bioinform.
|
| https://dblp.org/rdf/schema#publishedInJournal
|
Briefings Bioinform.
|
| https://dblp.org/rdf/schema#publishedInJournalVolume
|
21
|
| https://dblp.org/rdf/schema#publishedInJournalVolumeIssue
|
2
|
| https://dblp.org/rdf/schema#title
|
Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs.
|
| https://dblp.org/rdf/schema#wikidata
|
http://www.wikidata.org/entity/Q91250526 +
|
| https://dblp.org/rdf/schema#yearOfPublication
|
2020
|
| owl:sameAs |
https://doi.org/10.1093/BIB/BBY130 +
, http://dx.doi.org/10.1093/BIB/BBY130 +
, http://www.wikidata.org/entity/Q91250526 +
|
| rdf:type |
https://dblp.org/rdf/schema#Publication +
, https://dblp.org/rdf/schema#Article +
|
| rdfs:label |
Ying Hong Li et al.: Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs. (2020)
|
